R&D
AVEO Oncology Rejoices FDA Approval for TKI, Finds Able Partner in BMS to Trial Combo Therapy for Kidney Cancer
2021-03-13
Astellas Submits New Drug Application Targeting First ADC Approval for Metastatic Urothelial Cancer in Japan
2021-03-13
After Cardiovascular Disease, Novartis’ Rare Disease Drug Flops in Late-Stage Lung Cancer Study
2021-03-09
Gilead’s Breakthrough CAR-T Becomes First to Get FDA Approval for Indolent Follicular Lymphoma
2021-03-07
Massachusetts Cancer Startup to Fund Mission of Drugging the Undruggable with $107M Series C Round
2021-03-07
Tempest Lands Big Pharma Partnership to Trial Combo Therapy Against “Hard-To-Treat” Liver Cancer
2021-03-05
Neurocrine, Takeda Look to Build on Positives Post Luvadaxistat’s Schizophrenia Trial Failure
2021-03-03
Sanofi Joins Hands with German Biotech to Develop Improved AAV Capsids for Gene Therapies
2021-02-28
LATEST
Revolutionizing Treatment: ASGCT’s Clinical Trials Spotlight on Immunotherapy, Cancer Vaccines, and Auditory Diseases
2024-05-09
Advancing Health: ASGCT’s Clinical Trials Spotlight on Cell Therapy and Cell-Based Gene Therapy
2024-05-09
Infinitopes’ Article in Peer-Reviewed Journal Seeks to Unlock the Potential of Cancer Vaccines
2024-05-09
Profluent Achieves Human Genome Editing Milestone Using OpenCRISPR-1: The First AI-Generated, Open-Source Gene Editor
2024-05-08